MEDIFAST INC Common Stock
MEDUnited States
5 filed reports · 243 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 813 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 741 | Dec 2025 |
Financial data
243 concepts · 1,554 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial231 concepts · 1,420 facts · Dec 2023 to Jun 2026
- Stockholders equity (US GAAP)14 · Dec 2023 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation and exercise of stock options13 · Dec 2023 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents13 · Dec 2023 to Jun 2026
- Dividends payable current13 · Dec 2023 to Jun 2026
- Net income loss13 · Dec 2023 to Jun 2026
- Other comprehensive income loss net of tax portion attributable to parent13 · Dec 2023 to Jun 2026
- Share based compensation arrangement by share based payment award options outstanding number13 · Dec 2023 to Jun 2026
- Share based compensation arrangement by share based payment award options outstanding weighted average exercise price13 · Dec 2023 to Jun 2026
- Advertising expense12 · Dec 2023 to Jun 2026
- Allocated share based compensation expense12 · Dec 2023 to Jun 2026
- Comprehensive income net of tax12 · Dec 2023 to Jun 2026
- Cost of revenue (US GAAP)12 · Dec 2023 to Jun 2026
- Debt securities realized gain loss12 · Dec 2023 to Jun 2026
- Gross profit (US GAAP)12 · Dec 2023 to Jun 2026
- Income tax expense benefit12 · Dec 2023 to Jun 2026
- Nonoperating income expense12 · Dec 2023 to Jun 2026
- Operating income loss12 · Dec 2023 to Jun 2026
- Operating lease expense12 · Dec 2023 to Jun 2026
- Other comprehensive income loss available for sale securities adjustment net of tax12 · Dec 2023 to Jun 2026
- Other nonoperating income expense12 · Dec 2023 to Jun 2026
- Revenue12 · Dec 2023 to Jun 2026
- Selling general and administrative expense12 · Dec 2023 to Jun 2026
- Stock issued during period shares share based compensation12 · Dec 2023 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect11 · Dec 2023 to Jun 2026
Segment12 concepts · 134 facts · Dec 2023 to Jun 2026
- Allocated share based compensation expense12 · Dec 2023 to Jun 2026
- Cost of revenue (US GAAP)12 · Dec 2023 to Jun 2026
- Depreciation12 · Dec 2023 to Jun 2026
- Distribution12 · Dec 2023 to Jun 2026
- General and administrative expense (US GAAP)12 · Dec 2023 to Jun 2026
- Income tax expense benefit12 · Dec 2023 to Jun 2026
- Information technology and data processing12 · Dec 2023 to Jun 2026
- Net income loss12 · Dec 2023 to Jun 2026
- Nonoperating income expense12 · Dec 2023 to Jun 2026
- Revenue12 · Dec 2023 to Jun 2026
- Selling and marketing expense (US GAAP)12 · Dec 2023 to Jun 2026
- Segment expenditure addition to long lived assets2 · Mar 2025 to Mar 2026
Segments
134 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 134 facts
- Optavia134 · Dec 2023 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Nov 2025 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 3, 2026
- FY2026 Q1May 4, 2026
- FY2025 Q4Feb 17, 2026
- FY2025 Q3Nov 3, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.